朕天下娛樂城
Invest in 朕天下娛樂城
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
MARKSANS ?NSE
Marksans Pharma
?259.25-2.20 (0.84%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
257.29
Today’s high
263.79
52 week low
155.00
52 week high
266.60
Open price
260.99
Previous close
261.45
Live volume
6,10,699
Lower circuit
209.16
Upper circuit
313.74
Fundamentals
Market Cap
?11,841Cr
ROE
13.82%
P/E Ratio(TTM)
28.19
EPS(TTM)
9.27
P/B Ratio
3.92
Dividend Yield
0.34%
Industry P/E
33.86
Book Value
66.71
Debt to Equity
0.11
Face Value
1
Financial performance
MAR '26
Revenue (Cr)
?891
+15.07%
Profit (Cr)
?149
+31.08%
02505007501k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +23% |
| 3Y CAGR | +21% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +64% |
| 3Y CAGR | +27% |
About
Marksans Pharma is a trusted global pharmaceutical company that develops, manufactures, and distributes both over-the-counter (OTC) and prescription (Rx) drugs for regulated markets. Its guiding vision is to transform into a respected, profitable, and integrated global pharmaceutical enterprise by delivering quality formulations to people. The company's overall manufacturing capacity has impressively reached 26 billion units per year, a fourfold increase achieved over several years.;
CEO/MD
NA
Founded in
--
NSE symbol
MARKSANS
Shareholding Pattern
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Mutual Funds Invested (4)
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ?8,404.00 -125.00 (1.47%) | 21,286.25 | 113.51 | 24.39 | ||
PfizerPFIZER | ?4,528.10 -11.20 (0.25%) | 20,766.73 | 28.74 | 4.94 | ||
?1,458.50 +27.90 (1.95%) | 19,822.74 | 30.61 | 5.08 | |||
Granules IndiaGRANULES | ?787.00 +4.90 (0.63%) | 19,386.39 | 32.58 | 3.81 |
Livesquawk ?
Marksans Pharma plans to launch 50 products in the U.S. by FY '27.
R&D spend to remain 3% of revenue; Europe, Canada contributions expected FY '27.
Livesquawk ?
Marksans Pharma aims to boost its North American business by enhancing store brand presence.
The company targets doubling OTC revenue from U.S. store brands.
2026
26
May
Quarterly & Annual Result
Release date
5
Feb
Quarterly Result
Release date
2025
13
Nov
Quarterly Result
Release date
12
Aug
Quarterly Result
Release date
1AugDividendEx date?0.80per share
1
Aug
Dividend
Ex date
?0.80
per share
For each share you hold, you will receive ?0.80
Dividend amount?0.80 per share
Dividend TypeFinal
Ex Date1 Aug ‘25
Record Date1 Aug ‘25
Announcement date19 May ‘25
19MayDividendAnnounced?0.80per share
19
May
Dividend
Announced
?0.80
per share
For each share you hold, you will receive ?0.80
Dividend amount?0.80 per share
Dividend TypeFinal
Ex Date1 Aug ‘25
Record Date1 Aug ‘25
Announcement date19 May ‘25
2024
17SepDividendEx date?0.60per share
17
Sep
Dividend
Ex date
?0.60
per share
For each share you hold, you will receive ?0.60
Dividend amount?0.60 per share
Dividend TypeFinal
Ex Date17 Sep ‘24
Record Date17 Sep ‘24
Announcement date30 May ‘24
Events calendar
View upcoming events in other stocks